Biospecimen Bank
生物样本库
基本信息
- 批准号:10242156
- 负责人:
- 金额:$ 16.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-09-02 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:9p24Animal ModelAreaBiodistributionBiological AssayBiological Specimen BanksBiological Specimen databaseBiometryBiostatistics CoreBloodBlood Component RemovalBlood specimenBone MarrowCancer CenterCell SeparationCellsChromosomesCitiesCity of Hope Comprehensive Cancer CenterClassificationClinicalCollaborationsCollectionCommunitiesComplementComplexComprehensive Cancer CenterCore FacilityCytogeneticsCytometryDNA Sequencing FacilityDataData SetDatabasesDerivation procedureDevelopmentDiagnosisDrug KineticsEnrollmentEnsureFundingGene Expression ProfilingGenomicsGoalsHistologicHodgkin DiseaseHumanIL2RA geneImmuneImmunofluorescence ImmunologicImmunophenotypingIndividualInformaticsInfrastructureInstitutionLeukapheresisLinkLymphomaMalignant lymphoid neoplasmModelingMolecularMonitorMulticenter StudiesNon-Hodgkin&aposs LymphomaParaffinPathologicPathologyPatientsPerformancePhenotypePopulationPreparationProcessProgram Research Project GrantsQuality ControlRegistriesResearchResearch PersonnelResearch Project GrantsResearch SupportResourcesSamplingServicesShipsSpecimenStainsTimeTissue MicroarrayTissuesTumor TissueWorkbasiliximabbiomarker evaluationcareerchimeric antigen receptor T cellsdata repositorydesigndisease classificationimprovedinformatics infrastructureleukemia/lymphomamemberpatient derived xenograft modelprogramsprospectivequality assurancespatial relationshiptumortumor microenvironment
项目摘要
Core C is designed to meet the specific needs of the projects and at the same time draw on the strength of the
existing Cancer Center (CC) cores without unnecessary duplication of services. This Core will work closely and
synergistically with a number of CC Cores as well as other SPORE Cores to provide exceptional support for all
the proposed projects and possible inter-SPORE collaborations.
The overarching goals of this core is to provide high quality, well annotated and strictly quality controlled
biospecimens for the projects, to develop and implement assays needed for the analysis of the biospecimens
and to collaborate with Core B to build the informatics infrastructures to facilitate all aspects of research linked
to biospecimens.
Specific Aim 1 is to provides services in the following areas: (1) acquisition and banking of fresh and paraffin-
fixed tissues of lymphoma and blood and bone marrow (BM) samples obtained prospectively and
retrospectively from patients enrolled on the COH lymphoma SPORE; we will ensure rapid collection and
processing, proper storage and monitoring, and proper annotation and record keeping; (2) comprehensive
work-up of lymphoma specimens to ensure correct diagnosis and classification, including
immunohistochemical, flow cytometric, molecular pathologic, and cytogenetic studies; (3) performance and
assistance in routine histologic and immunohistochemical staining of lymphoma tissues and cells, as well as
specialized histologic services such as preparation of multi-tumor blocks or tissue microarrays to the
specifications of researchers. Additional specialized services will be performed according to the needs of the
projects with the collection of leukapheresis specimens to generate CAR-T cells (Project 1); characterization of
complex Hodgkin lymphoma and host cell populations through multispectral multiplexed immunofluorescence
(mIF) phenotyping and gene expression profiling (GEP) (Project 3); cytogenetic and genomic characterization
of lymphomas and the preparation of samples to generate primary patient-derived xenograft (PDX) non-
Hodgkin lymphoma models (Project 4).
Because of the complexity of the datasets associated with the functions of Core C, in Specific Aim 2, we will
collaborate with Core B (Research Informatics) to design, build, and integrate databases relevant to
biospecimens to improve their functionality and connectivity to support SPORE projects and collaborations on
other NCI-sponsored projects.
Core C 旨在满足项目的特定需求,同时利用
现有的癌症中心 (CC) 核心,无需不必要的重复服务。该核心将密切合作并
与许多 CC 核心以及其他 SPORE 核心协同作用,为所有用户提供卓越的支持
拟议的项目和可能的 SPORE 间合作。
该核心的总体目标是提供高质量、注释良好且严格的质量控制
项目的生物样本,开发和实施生物样本分析所需的检测方法
并与Core B合作建立信息学基础设施,以促进相关研究的各个方面
到生物样本。
具体目标 1 是在以下领域提供服务:(1) 新鲜石蜡的收购和储存
前瞻性获得的淋巴瘤组织以及血液和骨髓 (BM) 样本
对参加 COH 淋巴瘤 SPORE 的患者进行回顾性研究;我们将确保快速收集和
处理、适当的存储和监控以及适当的注释和记录保存; (2)综合性
对淋巴瘤标本进行检查以确保正确的诊断和分类,包括
免疫组织化学、流式细胞术、分子病理学和细胞遗传学研究; (3) 性能和
协助淋巴瘤组织和细胞的常规组织学和免疫组织化学染色,以及
专门的组织学服务,例如制备多肿瘤块或组织微阵列
研究人员的规格。根据需要,将提供额外的专业服务
收集白细胞分离标本以生成 CAR-T 细胞的项目(项目 1);的表征
通过多光谱多重免疫荧光观察复杂的霍奇金淋巴瘤和宿主细胞群
(mIF) 表型分析和基因表达谱 (GEP)(项目 3);细胞遗传学和基因组表征
淋巴瘤和样本制备以产生原发性患者来源的异种移植物(PDX)非
霍奇金淋巴瘤模型(项目 4)。
由于与Core C功能相关的数据集的复杂性,在具体目标2中,我们将
与核心 B(研究信息学)合作,设计、构建和集成与以下相关的数据库
生物样本,以改善其功能和连接性,以支持 SPORE 项目和合作
其他 NCI 资助的项目。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Wing C. Chan其他文献
Sequence comparison of putative regulatory DNA of the 5' flanking region of the myeloperoxidase gene in normal and leukemic bone marrow cells.
- DOI:
10.1097/mca.0b013e32832da06d - 发表时间:
1993-09-01 - 期刊:
- 影响因子:11.4
- 作者:
Garth E. Austin;L. Lam;Zaki;Wing C. Chan;T. Hodge;J. Hou;D. Swan;W. Zhang;M. Racine;C. Whitsett - 通讯作者:
C. Whitsett
Indolent T-cell lymphoproliferative disease of the gastrointestinal tract
胃肠道惰性 T 细胞淋巴增殖性疾病
- DOI:
- 发表时间:
2013 - 期刊:
- 影响因子:0
- 作者:
Anamarija M. Perry;R. Warnke;Qinglong Hu;P. Gaulard;C. Copie;Serhan Alkan;Huan;Jason X. Cheng;Chris M. Bacon;J. Delabie;Erik A. Ranheim;C. Kűcűk;Xiao;D. Weisenburger;E. Jaffe;Wing C. Chan - 通讯作者:
Wing C. Chan
Lymphomatous polyneuropathy. Biopsy of clinically involved nerve and successful treatment.
淋巴瘤性多发性神经病。
- DOI:
- 发表时间:
1991 - 期刊:
- 影响因子:0
- 作者:
D. Krendel;Robert L. Stahl;Wing C. Chan - 通讯作者:
Wing C. Chan
Human myeloperoxidase gene expression in acute leukemia.
急性白血病中人髓过氧化物酶基因的表达。
- DOI:
10.1182/blood.v74.6.2096.bloodjournal7462096 - 发表时间:
1989-11-01 - 期刊:
- 影响因子:20.3
- 作者:
S. R. Zaki;Garth E. Austin;D. Swan;Alagarsamy Srinivasan;Abdelsalam H. Ragab;Wing C. Chan - 通讯作者:
Wing C. Chan
Concurrent lymphocyte predominance Hodgkin's disease and T-cell lymphoma. A report of three cases.
并发淋巴细胞为主型霍奇金病和 T 细胞淋巴瘤。
- DOI:
- 发表时间:
1996 - 期刊:
- 影响因子:5.6
- 作者:
J. Delabie;T. Greiner;Wing C. Chan;D. Weisenburger - 通讯作者:
D. Weisenburger
Wing C. Chan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Wing C. Chan', 18)}}的其他基金
Cooperative role of TET2 and IDH2 mutations in angioimmunoblastic T-cell lymphomagenesis
TET2 和 IDH2 突变在血管免疫母细胞 T 细胞淋巴瘤发生中的协同作用
- 批准号:
10672370 - 财政年份:2021
- 资助金额:
$ 16.63万 - 项目类别:
Cooperative role of TET2 and IDH2 mutations in angioimmunoblastic T-cell lymphomagenesis
TET2 和 IDH2 突变在血管免疫母细胞 T 细胞淋巴瘤发生中的协同作用
- 批准号:
10453656 - 财政年份:2021
- 资助金额:
$ 16.63万 - 项目类别:
Pre-analytical variables of bioanalytes affecting the accuracy of PTCL diagnostic and prognostic genetic signatures
生物分析物的分析前变量影响 PTCL 诊断和预后遗传特征的准确性
- 批准号:
10300391 - 财政年份:2021
- 资助金额:
$ 16.63万 - 项目类别:
Cooperative role of TET2 and IDH2 mutations in angioimmunoblastic T-cell lymphomagenesis
TET2 和 IDH2 突变在血管免疫母细胞 T 细胞淋巴瘤发生中的协同作用
- 批准号:
10299140 - 财政年份:2021
- 资助金额:
$ 16.63万 - 项目类别:
Pre-analytical variables of bioanalytes affecting the accuracy of PTCL diagnostic and prognostic genetic signatures
生物分析物的分析前变量影响 PTCL 诊断和预后遗传特征的准确性
- 批准号:
10491082 - 财政年份:2021
- 资助金额:
$ 16.63万 - 项目类别:
Pre-analytical variables of bioanalytes affecting the accuracy of PTCL diagnostic and prognostic genetic signatures
生物分析物的分析前变量影响 PTCL 诊断和预后遗传特征的准确性
- 批准号:
10684317 - 财政年份:2021
- 资助金额:
$ 16.63万 - 项目类别:
Development of a Novel Clinical Diagnostic Assay for Peripheral T-cell Lymphoma (PTCL)
开发外周 T 细胞淋巴瘤 (PTCL) 的新型临床诊断方法
- 批准号:
9555564 - 财政年份:2018
- 资助金额:
$ 16.63万 - 项目类别:
Molecular diagnostic and prognostic signatures for PTCL
PTCL 的分子诊断和预后特征
- 批准号:
10017897 - 财政年份:2017
- 资助金额:
$ 16.63万 - 项目类别:
Molecular diagnostic and prognostic signatures for PTCL
PTCL 的分子诊断和预后特征
- 批准号:
10226182 - 财政年份:2017
- 资助金额:
$ 16.63万 - 项目类别:
Molecular Signatures to Improve Diagnosis and Outcome Pr
改善诊断和结果的分子特征
- 批准号:
7913564 - 财政年份:2009
- 资助金额:
$ 16.63万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
探索在急性呼吸窘迫综合征动物模型和患者长时间俯卧位通气过程中动态滴定呼气末正压的意义
- 批准号:82270081
- 批准年份:2022
- 资助金额:76 万元
- 项目类别:面上项目
脆性X综合征动物模型中异常视觉信息处理和视觉注意力的神经环路机制研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
无菌动物模型与单细胞拉曼技术结合的猴与人自闭症靶标菌筛选及其机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
雌激素抑制髓系白血病动物模型中粒细胞异常增生的机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目